Financhill
Back

Protalix BioTherapeutics Stock Predictions

Protalix BioTherapeutics Stock Forecast

  • Is Protalix BioTherapeutics Stock Undervalued?
    The current Protalix BioTherapeutics [PLX] share price is $1.10. The Score for PLX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Protalix BioTherapeutics Stock Go Up Next Year?

Data Unavailable

Protalix BioTherapeutics Stock Rating

Data Unavailable

Protalix BioTherapeutics Stock Price History

Is PLX stock going to rise?

  • The current trend is moderately bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protalix.com

52-Week Data

52-Week High:
1.90
52-Week Low:
0.82

Prediction Charts

Market Cap:
80.9M
Price in USD:
1.10
Volume:
124.33K
Beta:
0.66

Technical Analysis

SMA50:
1.04
SMA100:
1.10
SMA200:
1.29
52-Wk Change:
-35.67%

Stock Predictions

  • Is Protalix BioTherapeutics stock public?
    Yes, Protalix BioTherapeutics is a publicly traded company.
  • What is the Protalix BioTherapeutics stock quote today?
    The Protalix BioTherapeutics stock price is 1.10 USD today.
  • How to buy Protalix BioTherapeutics stock online?
    You can buy Protalix BioTherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 0.96 1.07 1.10 0.96
Sep-4 1.05 1.01 1.07 1.00
Sep-5 1.02 1.02 1.05 1.01
Sep-6 1.02 1.00 1.03 0.99
Sep-9 0.98 1.01 1.04 0.98
Sep-10 1.01 1.02 1.03 0.99
Sep-11 1.04 1.04 1.05 1.00
Sep-12 1.06 1.06 1.10 1.01
Sep-13 1.04 1.05 1.09 1.04
Sep-16 1.07 1.09 1.09 1.06
Sep-17 1.09 1.10 1.12 1.07
Sep-18 1.10 1.09 1.15 1.09
Sep-19 1.15 1.15 1.16 1.12
Sep-20 1.15 1.10 1.17 1.10

Protalix BioTherapeutics Earnings

Data Unavailable

Protalix BioTherapeutics Forecast Revenue Growth

Data Unavailable

* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.